In the present work, we have evaluated eight reportedly blood-specific mRNA markers (HBB, HBA, ALAS2, CD3G, ANK1, PBGD, SPTB and AQP9) in an attempt to determine the most suitable ones for use in forensic applications based on their sensitivities, specificities and performance with casework samples.
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Selection of highly specific and sensitive mRNA biomarkers for the identification of blood 
Introduction
The analysis of cell-specific mRNA expression has been proposed as a promising new method for the identification of body fluids. A number of mRNA markers have been identified for the forensically most relevant body fluids: blood, saliva, semen, vaginal secretions and menstrual blood [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . RNA is notorious for its rapid post-mortem and in vitro decay, but several reports have pointed out an unexpectedly high stability of RNA in forensic stains [18] [19] [20] .
The purpose of this study was to take a critical look at the various blood mRNA markers that have been described in the literature and to perform a comparative analysis of their sensitivity, specificity and performance with casework samples. Blood was chosen for its easy availability, stability and the number of reported markers [6] [7] [8] [9] [10] [13] [14] [16] [17] [19] [20] . The following blood markers were included in the study: HBA and HBB are the alpha-and betasubunits of hemoglobin A [21, 22] ; aminolevulinate synthase 2 (ALAS2) is an erythroid-specific mitochondrial enzyme, that catalyzes the first step in the heme biosynthetic pathway [23] ; CD3 gamma molecule (CD3G) is part of the T-cell receptor-CD3 complex, which plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways [24] ; ankyrin 1 (ANK1) is an erythrocyte membrane protein, which provides the primary linkage between the membrane skeleton and the plasma membrane [25] ; the erythroid form of porphobilinogen deaminase (PBGD) is the third enzyme of the heme biosynthetic pathway [26] ; β-spectrin (SPTB) is an erythrocyte membrane protein [27] ; Aquaporin (AQP9) is a water channel protein expressed in peripheral leukocytes [28] . AQP9 was chosen as one representative out of nine, all of which were stated by the authors [13] to be co-expressed in vaginal secretion.
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In the present study the eight reportedly blood specific mRNA markers listed above were tested in order to evaluate specificity and sensitivity. Initial experiments were conducted using singleplex reactions to determine which of the eight markers would be most suitable for inclusion in a blood identification multiplex system. Cross reactivity with several body fluids in addition to blood was observed for AQP9 and therefore it was excluded from further analyses. Two multiplex systems were developed using the remaining seven markers allowing for the simultaneous amplification of two (high sensitivity duplex with HBA and HBB) and five mRNA markers (medium sensitivity pentaplex with ALAS2, ANK1, CD3G, SPTB, and PBGD) in single PCR reactions. The specificity, sensitivity and suitability of use with forensic casework samples for both multiplex systems were evaluated. Additionally, the ability to identify the presence of blood in challenging environmentally compromised blood samples was demonstrated for both multiplex systems.
Materials and methods

Samples
Body fluids were collected from healthy volunteers with their informed consent. 10 µl or 50 µl aliquots of fresh blood (without anticoagulation treatment) or EDTA-blood or saliva or frozen semen were pipetted on cotton swabs and dried at room temperature. Vaginal secretions and menstrual blood were collected from the vagina on sterile cotton swabs and dried at room temperature.
Altogether, samples from 26 different donors were used for the initial sensitivity / specificity experiments and samples from 17 different donors for the specificity 5/38 studies with the multiplexes. For the dilution series EDTA-blood from 6 different donors was diluted in 0.9% NaCl to a final volume of 5 µl per swab.
Stains tested included 3 samples from proficiency trials / interlaboratory exercises and 28 forensic casework samples from 16 routine cases. Blood stains comprised swabs from various surfaces (e.g. floor, window sill, doorknob, knife, glass) and blood on different objects (e.g. clothing, shoes, wood, paper). Two stains were 2 and 11 years old, the others were less then a year old.
For the environmentally compromised bloodstains, 50 µl aliquots of human blood were dried onto cotton cloth. These samples were exposed to different EDTA-blood samples from 18 non-primate animal species (alligator, cat, cow, deer, dog, duck, ferret, frog, guinea pig, goat, horse, mouse, opossum, pig, rabbit, rooster, sheep, turtle) and 10 primate species (African green monkey, baboon, black howler monkey, chimpanzee, crab-eating macaque, pig-tailed macaque, rhesus monkey, spider monkey, spot-nosed guenon) were obtained from various sources: HemoStat Laboratories, Dixen, CA (cow, horse); Central Total RNA from 20 human tissues (adipose, bladder, brain, cervix, colon, esophagus, heart, kidney, liver, lung, ovary, placenta, prostate, skeletal muscle, small intestine, spleen, testes, thymus, thyroid, and trachea) included in the 
RNA extraction
Total RNA was extracted manually (i.e. organic extraction) as described previously [6] 
DNase treatment
Contaminating DNA was removed with the TURBO DNA-free kit (Applied Biosystems/Ambion AB, Rotkreuz, Switzerland and Austin, TX) or on-column with the RNase-free DNase set (Qiagen) according to the manufacturer's protocol.
RNA quantification
RNA was quantified as described previously [6] or with the Quant-iT RNA assay kit and the Qubit fluorometer (Invitrogen, Basel, Switzerland), according to the manufacturer's protocol.
Reverse transcription
For the reverse transcription (RT) reaction, the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen), random primer protocol, was used according to the manufacturer's instructions. Alternatively SuperScript III reverse transcriptase, 50 ng random primers and RNaseOUT (all from Invitrogen) were used for the RT reaction. cDNA was obtained in a final volume of 20 µl.
Appropriate volumes of total RNA extracts were utilized in the reverse transcription reactions in order to obtain a desired quantity. For those samples with insufficient quantities, a maximum volume of extract (8 or 11 µl, depending on the RT kit) was used. RT minus controls (without reverse transcriptase) were included (using the sample input quantities or extract volumes as the RT positive reactions) in order to identify possible genomic DNA contamination.
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Endpoint PCR HPLC-purified primers were purchased from Microsynth (St. Gallen, Switzerland). Primers for the amplification of gene specific sequences were obtained from published sources [6, 13, 14, 16] . Additional primer sets were designed for HBA, ANK1 and CD3G, using the Primer3 Software (Electronic supplementary data, Table S1 ). All primers were designed to overlap exon-exonjunctions or span an intron in order to ensure that the obtained products were not due to the presence of contaminating DNA. The forward primers were 5'-labelled
The following amplification conditions were used for the singleplex PCR reactions: The 25 µl reaction mix contained 3 µl cDNA or an equal amount of sterile water for non-template controls, 2 µl primer mix (see below), 1mM dNTPs (AB), 1x PCR Buffer I (AB), and 1.25U AmpliTaq Gold DNA Polymerase (AB).
Primer concentrations were as follows: HBB 0.04 µM, HBA 0.027 µM, ALAS2 0.08 µM, CD3G 0.8 µM, ANK1 0.8 µM, PBGD 0.8 µM, SPTB 0.8 µM, AQP9 0.04 µM. The amplification was performed on a GeneAmp PCR System 9700 (AB):
The initial denaturation was at 95°C for 11 min, followed by 35 Genetic Analyzer (AB). One microliter of the amplified sample was added to 9.7 RFUs was used.
Results
Singleplexes
Initial experiments were designed to attempt to confirm the specificity of the eight reportedly blood-specific mRNAs (HBB, HBA, ALAS2, CD3G, ANK1,
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PBGD, SPTB and AQP9). The sensitivity of each marker was also evaluated using singleplex reactions to determine which of the confirmed blood-specific markers should be included in subsequent multiplex development and validation studies. Total RNA was isolated from body fluid samples (blood, saliva, buccal swabs, semen, vaginal secretions, menstrual blood) from 26 different donors using a manual organic extraction. Fifty, ten and one nanogram of total RNA was reverse transcribed and cDNA amplified with singleplex PCR reactions. The use of 1 or 10 ng of total RNA appeared to be sufficient for detection of the mRNAs (Table 1 ). An inhibitory effect in the blood samples and an increase in the occurrence of false negative results in the non-blood samples was observed with 50 ng of input total RNA ( Table 1 Alternatively, a small level of carry-over of the inactivation resin into subsequent reactions could also affect efficiency as it is designed to sequester divalent cations (i.e. MgCl 2 ).
No reaction with up to 25 ng genomic DNA was ever observed with any of the tested blood markers (data not shown). Cross reactivity with vaginal secretion and low expression in saliva was confirmed with the RNA marker AQP9, which therefore was excluded from further investigations. Occasionally other false positive reactions were detected with 50 ng and 10 ng of input total RNA, but 12/38 normally significantly smaller peaks than those observed for the blood samples (Table 1) .
Multiplexes
An advantage of mRNA profiling for body fluid identification includes the ability to multiplex numerous markers allowing for built-in redundancy to account While simultaneous amplification of the markers included in the pentaplex was achieved, there were additional challenges with this multiplex. First, complete signal intensity balance was not achieved due to the differing levels of expression of the included markers (low to moderate). Additionally, an increased occurrence 13/38 of split peaks and noisy baselines were observed with the pentaplex system compared to the duplex system. No amplification peaks at marker positions were observed in the RT minus or PCR negative controls (data not shown). However, dye blobs at 60 bp and 220 bp were frequently observed. The appearance of saturation peaks as well as dye blobs was reduced and in many cases eliminated with the use of post PCR purification ( Fig. 1b and 1d ). The use of post-PCR purification also resulted in increased signal intensity, which was useful with detection of the lower abundance markers in the pentaplex system.
Sensitivity
Multiplex sensitivity was tested in two ways, a practical approach (Table 3) . HBB and HBA appeared to be the most sensitive markers, detecting as little as 0.001 ng of input total RNA. ALAS2, CD3G, ANK1 and SPTB showed a medium sensitivity with a detection limit of 0.1 to 0.01 ng of input total RNA, and PBGD was the least sensitive marker with a detection limit of 0.1 ng input total RNA. 
Forensic casework and mock casework stains
Environmentally exposed stains
A set of blood stains from a male and female donor (an additional female donor for the outside uncovered sample set was used due to unavailability of the original female donor for that exposure condition only) were exposed to a range of environmental conditions from 1 day to 1 year. For all of the samples except two, 3-7 mRNA markers were detected allowing for a successful identification of the presence of blood (Table 5) . Only HBB and HBA were detected for two outside samples (outside covered 3 days and outside uncovered 1 month), which demonstrates the suitability of use of the high sensitive duplex with challenging or more highly degraded casework samples. Additionally, full STR profiles were obtained from a majority (79%) of samples (Table 5 ). For five of the seven samples where a full profile was not obtained, partial profiles were recovered. No profile was obtained from the bloodstains from both the male and female donors that had been placed outside uncovered for 1 month. However, detection of the presence of blood (2 mRNA markers for the female sample and 5 mRNA markers for the male sample) was observed for these samples.
Specificity
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Initial evaluations of the specificity of the 7 blood markers in singleplex reactions indicated a high level of specificity for blood. In order to ensure that equivalent specificity would be obtained with the markers in the two multiplex formats, additional human biological fluid samples (blood, semen, saliva (liquid and buccal swabs), vaginal secretions, and menstrual blood) as well as twentyone human tissues (adipose, bladder, brain, cervix, colon, esophagus, heart, kidney, liver, lung, ovary, placenta, prostate, skeletal muscle, skin, small intestine, spleen, testes, thymus, thyroid, and trachea) were analyzed. Body fluids included analysis, the need for quantification to ensure that analytically optimal amounts of RNA are used.
In order to further evaluate the specificity of the blood markers, 1 ng of total RNA from human tissues was reverse transcribed and cDNA amplified with the duplex and pentaplex multiplex systems. Detection of multiple blood markers was observed for all tissues except placenta (Electronic supplementary data, Table S2a ). Based on these initial results, the specificity of the blood markers does not appear to be absolute. However, capillaries will likely be present in tissue samples in order to supply blood to the various tissues. Therefore, it is not possible to preclude the possibility that capillary blood is being detected in the tissue samples. Additionally, the total RNA from these tissues was obtained from commercial sources and not extracted in-house from actual tissue samples. Such RNA will be of superior quality to that obtained from dried biological stains (i.e.
less degraded and with a larger number average molecular weight) and may therefore effectively contain for each tested gene transcript a larger number of full length starting templates per ng of input total RNA. This might result in false positive reactions. Ideally, to confirm this hypothesis, total RNA extracts from dried tissue samples from clearly defined sources should be tested.
The species specificity of the blood markers was evaluated with 1 ng of total RNA isolated from animal and primate blood samples. The RNA was reverse transcribed and cDNA amplified with the duplex and pentaplex systems.
Detection of all seven markers was not observed for any or the animal or primate samples (Electronic supplementary data, Table S2b ). HBB was the only marker not detected in any of the animal samples. However, detection of the remaining markers in some domestic animals including cat, dog, guinea pig, mouse, rabbit, 18/38 rat and turtle was observed. This initial specificity testing was mainly performed with one sample per species and may therefore require additional testing with multiple samples within a species in order to make a more definitive assessment of the species specificity of these blood markers.
Discussion
The purpose of this study was to critically evaluate the various mRNA blood markers that have been described in literature and to compare their sensitivity, specificity and performance with casework samples. The focus of this study was on blood which is a frequently encountered biological fluid in forensic casework and for which a larger number of gene candidates have been reported.
Eight putative blood specific mRNA markers were tested in an initial screening experiment, with a limited number of samples, for their efficacy to positively identify blood, namely HBB, HBA, ALAS2, CD3G, ANK1, PBGD, SPTB and AQP9. Cross-reactivity of AQP9 with vaginal secretion and low expression in saliva was stated by the authors [13] and confirmed in our pre-evaluation and therefore was excluded from further investigations.
An advantage of mRNA profiling is the ability to multiplex numerous markers for the identification of one or several body fluids. It was not the primary intention of the authors to create a ready-to-use multiplex for the identification of blood, but instead to evaluate a set of blood markers under the same conditions for direct comparisons of their specificity, sensitivity and performance with casework samples. The optimization of a single multiplex system was challenging due to significant differences in marker abundance and/or amplification efficiencies. However, the development of separate high-and medium-sensitivity housekeeping genes would also be affected.
Remarkably low quantities of total RNA were needed to obtain a complete mRNA profile from blood. With 1 ng RNA all blood markers were detectable, but even with 0.001 ng RNA HBA, HBB and occasionally additional markers were detected. It proved to be important for the specificity of the method not to put too much RNA into the RT reaction and the optimal input is somewhat dependent upon the particular DNase treatment and buffers used.
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The seven tested blood mRNA markers performed well with casework and environmentally exposed samples. From almost all stains a good quality DNA profile and the positive identification of blood could be achieved. Even stains exposed to humidity and rain for up to one month could be identified as blood, despite no DNA profile being generated. The successful identification of blood using the two multiplex systems and the recovery of STR profiles from a majority of the samples tested indicate the potential suitability of use of this type of profiling approach (co-isolation followed by mRNA and STR profiling) in forensic casework. Improved analysis of degraded and highly compromised samples may be achieved in the future through the use of small RNA profiling (e.g. microRNA)
[ [35] [36] .
There was no cross-reactivity with other body fluids, except for occasional, often results in the appearance of foreign alleles ("allele drop-in") [29] and the same effects might also be observed with RNA multiplex systems. The identified blood specific mRNAs, while expressed abundantly in blood, are likely not to be completely absent in other cells. Therefore, it is critical that optimal reaction conditions as well as RNA input amounts be used in order to obtain accurate profiling results.
Some cross-reactivity of the RNA multiplexes with human tissues and animal blood was observed. Cross reactivity with human tissues could be ascribed to blood-supplying capillaries, which are likely present in tissue samples.
This finding is not desirable, but nevertheless not that disturbing, since tissues don't appear frequently in crime cases, unless a severely traumatized corpse is involved. Cross reactivity with animal blood was expected for non-human primate species, which shouldn't be a problem from the forensic point of view, since nonhuman primates are normally not involved in crime cases. The cross reactivity with other non-primate animal species (e.g. domestic animals), however, was unexpected and undesirable, as occasional contact with some of these animals at crime scenes is possible. No more than three markers were detected in a single animal species and therefore the inclusion of multiple blood markers in a mRNA body fluid identification multiplex system could allow for a determination of species if appropriate combinations of markers were selected. In addition the coextracted DNA would not show a result with human specific STR multiplexes, another requirement for the definite identification of human blood.
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In summary, the results of this study support the use of mRNA profiling for the positive identification of a forensically relevant biological fluid, namely blood.
Based on the observed specificities and sensitivities of the blood mRNA candidates, informed selections of the appropriate markers to be included in body fluid identification systems can be made. While the results in this study were obtained using a CE-based detection platform, the future of mRNA profiling in forensics could be a "body fluid identification chip" containing a low density array of cDNAs that would be able to interrogate a comprehensive set of candidate genes for each body fluid. Therefore, it is essential that additional testing and validation studies be performed on new candidates for all forensically relevant biological fluids in order to develop robust RNA profiling systems for use in forensic casework. (4) 383 (3) 1182 (3) 3088 (4) 0 (3) 1153 (3) 438 (4) 31/38 
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Electronic supplementary data 38/38 --+  ----Spot-nosed guenon  --+  --+  +  Alligator  --+  -+  +  -Cat 1  +  ------Cat 2  +  -+  ----Cow  -------Deer  -------Dog 1  +  ------Dog 2  +  ------Duck  -------Ferret  -------Frog  -------Guinea Pig  ------+  Goat  -------Horse  -------Mouse 1  --+  --+  -Mouse 2  -----+  -Opossum  -------Pig  -------Rabbit 1  --+  --+  +  Rabbit 2  --+  --+  -Rat  -----+  -Rooster  -------Sheep  -------Turtle  --+  +  -+  - 
